1. Home
  2. BENF vs BEAT Comparison

BENF vs BEAT Comparison

Compare BENF & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beneficient

BENF

Beneficient

HOLD

Current Price

$3.25

Market Cap

52.6M

Sector

Finance

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.97

Market Cap

48.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BENF
BEAT
Founded
2003
2015
Country
United States
United States
Employees
55
16
Industry
Blank Checks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
52.6M
48.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BENF
BEAT
Price
$3.25
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
24.5K
1.2M
Earning Date
02-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$30.01
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.54
52 Week High
$9.96
$4.00

Technical Indicators

Market Signals
Indicator
BENF
BEAT
Relative Strength Index (RSI) 46.53 49.69
Support Level $3.15 $0.91
Resistance Level $3.56 $1.28
Average True Range (ATR) 0.19 0.06
MACD 0.00 0.03
Stochastic Oscillator 39.53 53.85

Price Performance

Historical Comparison
BENF
BEAT

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: